SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹0.27 | ₹0.21 | ₹0.23 | ₹0.13 | ₹0.13 |
What is the latest Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹0.27 |
| Mar2024 | ₹0.21 |
| Mar2023 | ₹0.23 |
| Mar2022 | ₹0.13 |
| Mar2017 | ₹0.13 |
How is Earnings Per Share (EPS) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.27 | 28.57 | |
| Mar2024 | ₹0.21 | -8.70 | |
| Mar2023 | ₹0.23 | 76.92 | |
| Mar2022 | ₹0.13 | 0.00 | |
| Mar2017 | ₹0.13 | - | |
Compare Earnings Per Share (EPS) of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,742.8 Cr | -3.8% | 28.1% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -3.8% |
28.1% |
12.4% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses